Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Journal of Scleroderma and Related Disorders|April 6, 2022
Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohortIvan Foeldvari, Jens Klotsche, Kathryn S Torok, et al.The Journal of Allergy and Clinical Immunology|May 7, 2023
Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2Liang Chen, Anna Mamutova, Anna Kozlova, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 13, 2026
Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+-year results from a multicenter, open-label studyHermine I Brunner, Lyudmila Grebenkina, Irina Nikishina, et al.Annals of the Rheumatic Diseases|May 20, 2014
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trialHermine I Brunner, Nicolino Ruperto, Zbigniew Zuber, et al.The Journal of Rheumatology|August 5, 2025
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III StudyHermine I Brunner, César Pacheco-Tena, Ingrid Louw, et al.The Journal of Rheumatology|August 1, 2024
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III StudyHermine I Brunner, César Pacheco-Tena, Ingrid Louw, et al.Annals of the Rheumatic Diseases|May 17, 2017
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trialHermine I Brunner, Nicolino Ruperto, Nikolay Tzaribachev, et al.Arthritis Care & Research|November 3, 2020
Underdetection of Interstitial Lung Disease in Juvenile Systemic SclerosisIvan Foeldvari, Jens Klotsche, Bernd Hinrichs, et al.Arthritis Care & Research|March 31, 2021
Differences Sustained Between Diffuse and Limited Forms of Juvenile Systemic Sclerosis in an Expanded International CohortIvan Foeldvari, Jens Klotsche, Ozgur Kasapcopur, et al.Journal of Scleroderma and Related Disorders|June 8, 2023
Gender differences in juvenile systemic sclerosis patients: Results from the international juvenile scleroderma inception cohortIvan Foeldvari, Jens Klotsche, Ozgur Kasapcopur, et al.Pageof 4